Browse our library of reports, books and videos on developments taking place in health, care, life sciences and pharma.

Filter by:
All COVID-19 Diversity, Inclusion & Equality

COVID-19 and cancer recovery

Read more

COVID-19 and cancer recovery

Ben Richardson, Scott Bentley & Matt Ware

COVID-19 and cancer recovery

Ben Richardson, Scott Bentley & Matt Ware

This report was produced throughout the Autumn and Winter of 2020 by the healthcare consulting and analytics company Carnall Farrar. The report received guidance and chairmanship from Professor Sir Mike Richards. The insights, quotes and conclusions contained within the report have been based on detailed interviews with 56 cancer clinicians, academics, executives and managers from within NHS providers, universities and charities. A list of those interviewed can be found in the appendix. This work uses data provided by patients and collected by the NHS as part of their care and support.

The ambition of this report is to highlight the ongoing impact of COVID-19 upon cancer services and cancer patients within the NHS. It recognises that cancer teams across the country have embraced service redesign in many guises to adapt to the new operating environment as part of wider NHS innovation to continue to meet the needs of their patients.

The development, peer review and publication of this report has been commissioned and funded by Roche Products Ltd (UK). Roche has not sought to steer or influence the interviews or the creation of this report in terms of questions asked or themes covered. Roche supports sharing this report to help the NHS improve patient outcomes in cancer.

 

The impact of COVID-19 on cancer

Read more

The impact of COVID-19 on cancer

Ben Richardson, Scott Bentley & Nour Mohanna

The impact of COVID-19 on cancer

Ben Richardson, Scott Bentley & Nour Mohanna

This is an update to our earlier report on the impact of the pandemic on cancer services and outcomes, and possible routes to recovery (read the full report here). Now that full data on the first wave has been released, we are providing our updated analysis.

Our earlier analysis accurately projected that the first COVID-19 wave would last between three and six months, which we estimated would result in 3,600 to 7,200 excess cancer deaths. We concluded that recovering the backlog and resuming cancer services would require significant work. These estimates were based on a larger drop in urgent referrals, as was the case at the time of writing the first report. The updated estimates that we provide in the current report on the five observed months of disruption corresponding to the first COVID wave, with the updated drop in referrals, fall in line with our original predictions. The same applies to the estimates on number of excess cancer deaths, changes in survival rates and anticipated stage distribution at diagnosis.

Cardio vascular disease and COVID-19

Read more

Cardio vascular disease and COVID-19

Ben Richardson, Scott Bentley, Anna Fry & Nour Mohanna

Cardio vascular disease and COVID-19

Ben Richardson, Scott Bentley, Anna Fry & Nour Mohanna

The burden of cardiovascular diseases (CVD) is huge in the UK. Approximately 7.6 million people in the UK are affected by CVD, which accounts for approximately 164,000 deaths per year. COVID-19 has substantially impacted CVD management across the board, including prevention, referrals, diagnosis, treatment and rehabilitation. In particular, health checks have dropped by 97%, which is a significant indicator of a decrease in screening and prevention, and consequently, to the initiation of preventative medicines, especially statins. While the shift to virtual appointments has been celebrated, in-person primary care attendance has decreased by 42%, which has significant implications on procedures that traditionally need in-person presence, such as measuring blood pressure and performing pulse checks. CVD referrals have also dropped by 43% which means that patients are not being referred for further specialist opinion. Indeed, this disruption has affected CVD services across the pathway, with a 19% to 45% reduction in elective procedures, a 41% to 44% drop in elective imaging, a 53% decrease in emergency admissions, and 36% drop in cardiac rehabilitation group exercise.

Understanding and addressing ethnicity and mortality in hospital activity during Covid

Read more

Understanding and addressing ethnicity and mortality in hospital activity during Covid

CF

Understanding and addressing ethnicity and mortality in hospital activity during Covid

CF

It is now well understood that Covid-19 has not just extracted a terrible toll on the elderly population but that it has also had a disproportionate impact on minority groups. In this report we examine what the impact has been and also what we can do about it.

 

Disruption and recovery of cancer from COVID-19

Read more

Disruption and recovery of cancer from COVID-19

Disruption and recovery of cancer from COVID-19

It is becoming increasingly clear that one of the biggest threats to health in the UK brought on by the COVID-19 pandemic, apart from COVID-19 itself, is to cancer services and cancer patients. The major disruptions to the cancer pathway have effectively stopped cancer screening, reduced referrals by more than 40%, and as a consequence have impacted considerably on cancer diagnosis and treatment, (including surgery, chemotherapy, and radiotherapy). In addition, there has been a major disruption to clinical research activity, including access of patients to innovative clinical trials.

Building a resilient system

Read more

Building a resilient system

Liz Knight, Danny Silk & Anne Rainsberry

Building a resilient system

Liz Knight, Danny Silk & Anne Rainsberry

 

System resilience is an active, integrated approach to responding to crises, including surges in demand, without losing core functions. Resilient systems are able to shift service delivery and flex the workforce as needed to respond to rapid change. To develop resilient systems, leaders need to focus on person centred, place-based care supported by an empowered and nurtured workforce, underpinned by place-based estates, integrated data and aligned finance. The way in which leaders lead is also evolving, along with a real energy to take the opportunity given by the pandemic to do things differently.

 

Previous article
Next article Close